MedPath

SironRX Therapeutics, Inc.

SironRX Therapeutics, Inc. logo
🇺🇸United States
Ownership
Private
Established
2010-01-01
Employees
1
Market Cap
-
Website
http://www.sironrx.com

Study to Evaluate the Safety and Efficacy of Dermal Injections of JVS-100 Given to Adults Receiving Median Sternotomy

Phase 1
Conditions
Median Sternotomy
Interventions
Biological: JVS-100 or placebo
First Posted Date
2012-08-03
Last Posted Date
2013-07-23
Lead Sponsor
SironRX Therapeutics, Inc.
Target Recruit Count
25
Registration Number
NCT01657045
Locations
🇺🇸

University of Utah Hospital, Salt Lake City, Utah, United States

🇺🇸

Sentara Cardiovascular Research Institute, Norfolk, Virginia, United States

🇺🇸

Pepin Heart Institute, Tampa, Florida, United States

and more 3 locations
© Copyright 2025. All Rights Reserved by MedPath